Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mark, Hives"'
Autor:
Eduard, GONDAS1, Mark, HIVES1, Jan, KLIMENT1, Monika, KMETOVA SIVONOVA1 murin@jfmed.uniba.sk, Dusan, DOBROTA1, Radovan, MURIN1
Publikováno v:
Bratislava Medical Journal / Bratislavské Lekárske Listy. 2022, Vol. 123 Issue 7, p487-490. 4p.
Autor:
Ján Kliment, Daniel Evin, M Sivonova, R. Dusenka, Henrieta Drobková, Jana Jurečeková, Marian Grendar, Mark Hives, Anna Tomascova, Peter Kaplan
Publikováno v:
Anticancer Research. 40:6257-6264
BACKGROUND/AIM The aim of this study was to evaluate the relationship between MDM2 T309G polymorphism and prostate cancer risk in the Slovak population and the association of this polymorphism with MDM2 expression and clinicopathological features. MA
Autor:
Dusan Dobrota, Henrieta Drobková, Monika Kmeťová Sivoňová, Ján Kliment, Mark Hives, Jana Jurečeková, Daniel Evin
Publikováno v:
Oncology Letters
Sex steroid hormones have important roles in the function of the prostate; however, they may also serve as factors in the initiation and progression of carcinogenesis. Estrogens, acting through estrogen receptors, may significantly affect prostate ca
Autor:
Monika Kmetova, Sivonova, Jana, Jurecekova, Peter, Kaplan, Mark, Hives, Marian, Grendar, Anna, Tomascova, Robert, Dusenka, Henrieta, Drobkova, Daniel, Evin, Jan, Kliment
Publikováno v:
Anticancer research. 40(11)
The aim of this study was to evaluate the relationship between MDM2 T309G polymorphism and prostate cancer risk in the Slovak population and the association of this polymorphism with MDM2 expression and clinicopathological features.The MDM2 T309G pol
Autor:
Mark Hives, Klaudia Holeckova, Maria Skerenova, Katarina Baluchova, Ludovit Musak, Jan Kliment
Publikováno v:
In Vivo
Background/aim The aim of this study was to analyse the genetic profiles of metastatic castration-resistant prostate cancer (mCRPC) by using next generation sequencing to identify variants with pathogenic potential in nine DNA repair genes - BRCA1, B